Lv2
150 积分 2023-08-06 加入
Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma
1天前
待确认
Biomarkers of hepatocellular carcinoma: status and prospects
18天前
已关闭
Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
3个月前
已完结
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab
3个月前
已完结
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
4个月前
已完结
Dichotomizing continuous predictors in multiple regression: a bad idea
4个月前
已完结
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
4个月前
已完结
Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
4个月前
已完结
Tumour burden score combined with albumin‐to‐alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma
4个月前
已完结
Combination of crafity score with alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
4个月前
已完结
皖公网安备34019202002308
